AGP Executive Report
Last update: 9 hours agoSick Leave Reform: France is set to cap sick-leave prescriptions starting September 2026, with an initial maximum of 31 days and extensions limited to 62 days each, as the country targets spiraling costs tied to work absences. Nutrition & Heart Health: A large French-led study in the European Heart Journal links eight common food preservatives to higher risks of high blood pressure and cardiovascular disease, raising questions about everyday exposure to processed foods. Ophthalmology Update: Nicox says its glaucoma eye drop NCX 470 received positive pre-submission feedback from China’s CDE, paving the way for an NDA filing in China and a follow-on submission to the US FDA expected in summer 2026. Digital Child Safety: The UK Home Office knew an AI age-check tool for migrant children was flawed but plans to roll it out anyway, spotlighting accuracy and fairness concerns. Ebola Funding: The EU announced a €493m package to support the Ebola response in the Great Lakes region and Uganda, covering emergency care, vaccines research, and health-system strengthening. Agri-Tech & Biotech: University of Hyderabad alumni-backed ATGC Biotech showcased pheromone-based crop protection at Bharat Innovates 2026 in France, aiming to replace conventional insecticides with more sustainable approaches.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/81771ed4-94f7-45af-a2bb-938b992b56e0/north-america-ear-health-market-size-2025-to-2035-usd-billion-.png)
